Passage BIO, Inc.·4

Feb 14, 4:57 PM ET

Goldsmith Bruce A 4

4 · Passage BIO, Inc. · Filed Feb 14, 2022

Insider Transaction Report

Form 4
Period: 2022-02-10
Goldsmith Bruce A
DirectorCEO and President
Transactions
  • Award

    Stock Option (right to buy)

    2022-02-10+400,000400,000 total
    Exercise: $4.52Exp: 2032-02-09Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]The stock option vests as to 1/48 of the total shares monthly beginning on March 10, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT